Natera (NTRA) Competitors

Natera (NASDAQ:NTRA) and Fresenius Medical Care (NYSE:FMS) are both large-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their media sentiment, institutional ownership, profitability, dividends, valuation, earnings, community ranking, risk and analyst recommendations.

Does the MarketBeat Community believe in NTRA or FMS?

Natera received 68 more outperform votes than Fresenius Medical Care when rated by MarketBeat users. Likewise, 68.96% of users gave Natera an outperform vote while only 54.72% of users gave Fresenius Medical Care an outperform vote.

Company	Underperform	Outperform
Natera	Outperform Votes 491 68.96%	Underperform Votes 221 31.04%
Fresenius Medical Care	Outperform Votes 423 54.72%	Underperform Votes 350 45.28%

Do analysts recommend NTRA or FMS?

Natera presently has a consensus target price of $175.76, suggesting a potential upside of 18.40%. Fresenius Medical Care has a consensus target price of $25.30, suggesting a potential upside of 2.68%. Given Natera's stronger consensus rating and higher possible upside, analysts clearly believe Natera is more favorable than Fresenius Medical Care.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Natera	0 Sell rating(s)	0 Hold rating(s)	16 Buy rating(s)	0 Strong Buy rating(s)	3.00
Fresenius Medical Care	0 Sell rating(s)	2 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.33

Is NTRA or FMS more profitable?

Fresenius Medical Care has a net margin of 3.43% compared to Natera's net margin of -14.01%. Fresenius Medical Care's return on equity of 6.04% beat Natera's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Natera	-14.01%	-26.23%	-14.27%
Fresenius Medical Care	3.43%	6.04%	2.69%

Do insiders & institutionals have more ownership in NTRA or FMS?

99.9% of Natera shares are held by institutional investors. Comparatively, 8.4% of Fresenius Medical Care shares are held by institutional investors. 7.6% of Natera shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Which has stronger earnings & valuation, NTRA or FMS?

Fresenius Medical Care has higher revenue and earnings than Natera. Natera is trading at a lower price-to-earnings ratio than Fresenius Medical Care, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Natera	$1.70B	11.83	-$434.80M	-$1.53	-97.03
Fresenius Medical Care	$19.34B	0.75	$540.07M	$0.99	24.89

Which has more volatility & risk, NTRA or FMS?

Natera has a beta of 1.8, meaning that its share price is 80% more volatile than the S&P 500. Comparatively, Fresenius Medical Care has a beta of 0.93, meaning that its share price is 7% less volatile than the S&P 500.

Does the media prefer NTRA or FMS?

In the previous week, Natera had 22 more articles in the media than Fresenius Medical Care. MarketBeat recorded 25 mentions for Natera and 3 mentions for Fresenius Medical Care. Natera's average media sentiment score of 1.28 beat Fresenius Medical Care's score of 1.05 indicating that Natera is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Natera	17 Very Positive mention(s)	0 Positive mention(s)	5 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Fresenius Medical Care	3 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Natera beats Fresenius Medical Care on 11 of the 18 factors compared between the two stocks.